McPherson's (ASX:MCP) said its McPherson's Consumer Products subsidiary entered into a pharmacy wholesaler agreement with Symbion for a three-year term starting on June 1, according to a Thursday Australian bourse filing.
Under the group's new operating model announced on Feb. 24, the current annual revenue of about AU$10 million to AU$15 million from retailers, previously serviced through the direct-to-store model, will now be serviced through its wholesale relationship with Symbion.
The company's shares were up nearly 1% in recent Thursday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。